期刊文献+

TALENs介导的Nanog基因表达下调对宫颈癌HeLa细胞恶性行为的影响 被引量:3

The Effect of TALENs-mediated Downregulation Expression of Nanog on Malignant Behavior of Cervical Cancer HeLa Cells
原文传递
导出
摘要 目的研究Nanog表达下调对宫颈癌HeLa细胞恶性行为的影响。方法通过基因编辑工具转录激活样效应器核酸酶(TALENs)介导Nanog下调表达,基因测序分析Nanog的突变情况;挑取单个细胞培养以筛选出Nanog明显下调表达的单克隆HeLa细胞;RT-PCR检测mRNA表达水平;Western blot检测蛋白表达水平;HeLa细胞的集落形成能力、侵袭性及耐药性分别通过集落形成实验、Transwell侵袭实验及药物敏感性实验检测。结果 TALENs成功介导Nanog基因突变并导致其下调表达,Nanog突变的单克隆HeLa细胞Nanog mRNA和蛋白表达水平较野生型HeLa细胞均下调表达(P<0.05)。Nanog突变单克隆HeLa细胞相对于野生型HeLa细胞表现出明显减弱的侵袭、集落形成及化疗药物抵抗能力(P<0.05)。结论 Nanog突变减弱HeLa细胞的恶性行为,下调或沉默Nanog表达有望成为一种新型的治疗宫颈癌策略。 Objective To study the effect of downregulation expression of Nanog on malignant behavior of cervical cancer HeLa cells.Methods Gene editing tool TALENs was employed to induce downregulation expression of Nanog,and Nanog mutation was evaluated by sequencing.RT-PCR and Western blot was used to detect the mRNA and protein expression level,respectively.Colony-formation assay, Transwell invasion assay,and chemotherapy sensibility assay was carried out to assess the capacity of colony-formation,invasion,and chemoresistance,respectively.Results TALENs successfully induced Nanog mutation and downregulated Nanog expression.Nanog mRNA and protein expression of Nanog-mutated monoclonal HeLa cells downregulated 3times compared to thoses of wild-type HeLa cells(P〈0.05).Additionally,significant weakened abilities of colonyformation,invasion,and chemoresistance in monoclonal HeLa cells were observed when compared to those of wildtype HeLa cells(P 0.05).Conclusion Nanog mutation attenuates the malignant behavior of HeLa cells.Importantly,downregulation or silencing of Nanog is promising to be a novel strategy for the treatment of cervical carcinoma.
出处 《四川大学学报(医学版)》 CAS CSCD 北大核心 2016年第1期23-27,共5页 Journal of Sichuan University(Medical Sciences)
关键词 TALENs NANOG HELA细胞 宫颈癌 TALENs Nanog HeLa cells Cervical cancer
  • 相关文献

参考文献24

  • 1Missaoui N,Hmissa S,Trabelsi A,et al.Promoter hypermethylation of CDH13,DAPK1and TWIST1genes in precancerous and cancerous lesions of the uterine cervix.Pathol Res Pract,2011;207(1):37-42.
  • 2Wang JT,Ding L,Jiang SW,et al.Folate deficiency and aberrant expression of DNA methyltransferase 1 were associated with cervical cancerization.Curr Pharm,2014;20(11):1639-1646.
  • 3Punt S,Thijssen VL,Vrolijk J,et al.Galectin-1,-3and-9expression and clinical significance in squamous cervical cancer.PLoS One,2015;10(6):e0129119.doi:10.1371/journal.pone.0129119.
  • 4Attaleb M,El-hamadani W,Khyatti M,et al.Status of p16(INK4a)and E-cadherin gene promoter methylation in Moroccan patients with cervical carcinoma.Oncol Res,2009;18(4):185-192.
  • 5Zhang Y,Chen FQ,Sun YH,et al.Effects of DNMT1silencing on malignant phenotype and methylated gene expression in cervical cancer cells.J Exp Clin Cancer Res,2011;30:98.doi:10.1186/1756-9966-30-98.
  • 6Go MJ,Takenaka C,Ohgushi H.Forced expression of Sox2or Nanog in human bone marrow derived mesenchymal stem cells maintains their expansion and differentiation capabilities.Exp Cell Res,2008;314(5):1147-1154.
  • 7Pan G,Pei D.The stem cell pluripotency factor NANOG activates transcription with two unusually potent subdomains at its C terminus.J Biol Chem,2005;280(2):1401-1407.
  • 8Wu J,Tzanakakis ES.Distinct allelic patterns of Nanog expression impart embryonic stem cell population heterogeneity.PLoS Comput Biol,2013;9(7):e1003140.doi:10 .1371/journal.pcbi.1003140.
  • 9Luo Y,Lim CL,Nichols J,et al.Cell signalling regulates dynamics of Nanog distribution in embryonic stem cell populations.J R Soc Interface,2012Oct 10.[Epub ahead of print].
  • 10Bourguignon LY,Earle C,Wong G,et al.Stem cell marker(Nanog)and Stat-3 signaling promote MicroRNA-21expression and chemoresistance in hyaluronan/CD44-activated head and neck squamous cell carcinoma cells.Oncogene,2012;31(2):149-160.

同被引文献31

  • 1Ben - Porath I, Thomson MW, Carey V J, et al. An embryonic stem cell - like gene expression signature in poorly differentiated aggressive human tumors[J]. Nat Genet, 2008, 40(5) : 499 - 507.
  • 2A1 - Hajj M, Wicha MS, Benito - Hernandez A, et al. Prospec- tive identification of tumorigenic breast cancer cells[J]. Proc Natl Acad Sci U S A, 2003, 100(7) : 3983 -3988.
  • 3Ginestier C, Hur MH, Charafe - Jauffret E, et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome [ J ]. Cell Stem Cell, 2007, 1 (5) : 555 - 567.
  • 4Potten CS, Loeffler M. Stem ceils : attributes, cycles, spirals, pit- falls and uncertaineies. Lessons for and from the crypt[ J]. Devel- opment, 1990, 110(4): 1001-1020.
  • 5Hill RP. Identifying cancer stem ceils in solid tumors: case not proven[J]. Cancer Res, 2006, 66(4) : 1891 - 1895.
  • 6Mitsui K, Tokuzawa Y, Itoh H, et al. The homeoprotein Nanog is required for maintenance of pluripotency in mouse epilbalst and ES cells[J]. Cell, 2003, 113(5) : 631 -642.
  • 7Wang SH, Tsai MS, Chiang MF, et al. A novel NK - type home- box gene, ENK (early embryo specific NK ), preferentially ex- pressed in embryonic stem cells[J]. Gene Expr Patterns, 2003,3 (1): 99-103.
  • 8Hart AH, Hartley L, lbrahim M, et al. Identification, cloning and expression analysis of the pluripotency promoting Nanog genes in mouse and human[J]. Dev Dyn, 2004, 230(1) : 187 -198.
  • 9Silva J, Nichols J, Theunissen TW, et al. Nanog is the gateway to the pluripotent ground state [ J ]. Cell, 2009, 138 ( 4 ) : 722 - 737.
  • 10Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined fac- tors[J]. Cell, 2006, 126(4) : 663 -676.

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部